5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis
The rapidly spreading novel coronavirus has rattled the stock market and significantly disrupted economic activities worldwide — denting demand, hurting supply chain, slowing down production activities and temporary closure of brick-and-mortar locations. As a result, U.S. consumer confidence in March 2020 fell to the lowest level since June 2017. The deadly virus has already started taking a toll on employment and household income.
Well we still don’t know how long this battle with COVID-19 will be. But meanwhile policymakers are using every tool — slashing benchmark interest rate and announcing stimulus plan — to halt the economic meltdown. President Trump signed a $2-trillion economic relief package aimed at assisting workers, small industries and distressed companies on the brink of extinction. To further blunt the coronavirus-inflicted damage, the President is pushing for an infrastructure package, citing low interest rate environment.
Now the big question is what strategy investors should apply. Is it time to get rid of stocks in your portfolio and wait for a conducive investing environment? Or is it time to spot those stocks that are trading cheap but fundamentally sound considering their long-term perspective?
Warren Buffett once said, "We simply attempt to be fearful when others are greedy and to be greedy only when others are fearful." With the stock market in doldrums, fear is widespread, so its time to be greedy.
Here's an All-Weather Strategy
Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound. There are a number of ratios to identify value stocks but none alone can conclusively determine their inherent potential.
Each ratio helps an investor to understand a particular aspect of the company’s business. One such ratio, Price to Cash Flow (or P/CF), can work wonders in stock picking, if used prudently. This metric evaluates the market price of a stock relative to the amount of cash flow that the company is generating on a per share basis – the lower the number, the better.
You must be wondering why we are considering this when the most widely used valuation metric is Price/Earnings (or P/E). Well, one of the important factors that makes P/CF a highly dependable metric is that operating cash flow adds back non-cash charges such as depreciation and amortization to net income, truly diagnosing the financial health of a company.
Analysts caution that a company’s earnings are subject to accounting estimates and management manipulation. Then again, cash flow is quite reliable. Net cash flow unveils how much money a company is actually generating and how effectively management is deploying the same.
A positive cash flow indicates an increase in the company’s liquid assets. This gives the company the means to settle debt, shell out for its expenses, reinvest in its business, endure downturns and finally undertake shareholder-friendly moves. Negative cash flow implies a decline in the company’s liquidity, which, in turn, lowers its flexibility to support these endeavors.
However, an investment decision solely based on the P/CF metric may not fetch the desired results. To identify stocks that are trading at a discount, you should expand your search criteria and take into account price-to-book ratio, price-to-earnings ratio and price-to-sales ratio. Adding a favorable Zacks Rank and a Value Score of A or B to your search criteria should lead to even better results as these eliminate the chance of falling into a value trap.
The Bargain Hunting Strategy
Here are the parameters for selecting true value stocks:
P/CF less than or equal to X-Industry Median.
Price greater than or equal to 5: The stocks must all be trading at a minimum of $5 or higher.
Average 20-Day Volume greater than 100,000: A substantial trading volume ensures that the stock is easily tradable.
P/E using (F1) less than or equal to X-Industry Median: This parameter shortlists stocks that are trading at a discount or are equal to its peers.
P/B less than or equal to X-Industry Median: A lower P/B compared with the industry average implies that there is enough room for the stock to gain.
P/S less than or equal to X-Industry Median: The P/S ratio determines how a stock price compares to the company’s sales — the lower the ratio the more attractive the stock is.
PEG less than 1: The ratio is used to determine a stock's value by taking the company's earnings growth into account. PEG ratio gives a more complete picture than P/E ratio. A value of less than 1 indicates that the stock is undervalued and that investors need to pay less for a stock that has robust earnings growth prospect.
Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.
Value Score of less than or equal to B: Our research shows that stocks with a Style Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.
Here are five of the 12 stocks that qualified the screening:
Blucora, Inc. BCOR, which provides technology-enabled financial solutions, carries a Zacks Rank #2 and has an expected EPS growth rate of 20% for 3-5 years. The company has a trailing four-quarter positive earnings surprise of 17.2%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
Sanmina Corporation SANM provides integrated manufacturing solutions, components, products and repair, logistics and after-market services. This Zacks Rank #2 company has an expected EPS growth rate of 12% for 3-5 years. The company has a trailing four-quarter positive earnings surprise of 16.1%, on average.
Meritage Homes Corporation MTH, which designs and builds single-family homes, has an expected EPS growth rate of 6.8% for 3-5 years. This Zacks Rank #2 company has a trailing four-quarter positive earnings surprise of 22.1%, on average.
Select Medical Holdings Corporation SEM, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers, has an expected EPS growth rate of 15% for 3-5 years. This Zacks Rank #2 company has a trailing four-quarter positive earnings surprise of 24.8%, on average.
Foundation Building Materials, Inc. (FBM), which distributes building products, has an expected EPS growth rate of 12.1% for 3-5 years. This Zacks Rank #2 company has a trailing four-quarter positive earnings surprise of 41.2%, on average.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sanmina Corporation (SANM) : Free Stock Analysis Report
Meritage Homes Corporation (MTH) : Free Stock Analysis Report
Select Medical Holdings Corporation (SEM) : Free Stock Analysis Report
Blucora, Inc. (BCOR) : Free Stock Analysis Report
Foundation Building Materials, Inc. (FBM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
